SCHEMBL3226941

SCHEMBL3226941

Cc1ccc(C2(C)CC(C)CC(O)C2C(=O)O)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 13/20 0.40
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
EPHX2 P34913 1/20 0.35
ALDH1A1 P00352 2/20 0.34
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 1/20 0.32
KMO O15229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1779901 0.88 MEN1 (0.37) CCR2KMT2AMEN1EPHX2ALDH1A1
SCHEMBL3233210 0.82 CCR2 (0.49) CCR2ALDH1A1
SCHEMBL3235269 0.76 CCR2 (0.40) CCR2KMT2AMEN1EPHX2ALDH1A1
SCHEMBL1779902 0.73 CCR2 (0.40) CCR2KMT2AMEN1EPHX2ALDH1A1
SCHEMBL1781978 0.71 CCR2 (0.42) CCR2KMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL1779888 0.68 MEN1 (0.37) CCR2KMT2AMEN1EPHX2ALDH1A1
SCHEMBL1781951 0.68 CCR2 (0.81) CCR2
Bicarbonate SCHEMBL14237079 0.68 CCR2 (0.47) CCR2KMT2AMEN1KMO
SCHEMBL1780501 0.67 CCR2 (0.47) CCR2KMT2AMEN1ALDH1A1RAB9A
SCHEMBL1779889 0.66 CCR2 (0.40) CCR2KMT2AMEN1EPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507559-B2 Cyclohexenyl modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY (US) 2013-08-13 US disclosed
EP-2318352-B1 CYCLOHEXENYL COMPOUNDS AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2012-12-19 EP disclosed
WO-2010009068-A2 CYCLOHEXENYL MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2010-01-21 WO disclosed